Heineken NV (OTCMKTS:HEINY – Get Free Report) was the recipient of a significant decrease in short interest in October. As of October 15th, there was short interest totaling 5,995 shares, a decrease of 85.0% from the September 30th total of 39,933 shares. Currently, 0.0% of the shares of the stock are short sold. Based on an average daily volume of 497,227 shares, the short-interest ratio is presently 0.0 days.
Wall Street Analysts Forecast Growth
Several analysts have recently commented on HEINY shares. Barclays restated an “overweight” rating on shares of Heineken in a research report on Monday, October 5th. Royal Bank Of Canada reaffirmed a “sector perform” rating on shares of Heineken in a report on Tuesday, August 11th. Finally, Deutsche Bank Aktiengesellschaft reiterated a “hold” rating on shares of Heineken in a research note on Wednesday, September 16th. Two analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to MarketBeat.com, Heineken presently has an average rating of “Hold”.
Read Our Latest Stock Report on HEINY
Heineken Stock Performance
OTCMKTS:HEINY opened at $43.00 on Tuesday. The company has a current ratio of 0.75, a quick ratio of 0.53 and a debt-to-equity ratio of 0.75. Heineken has a 12-month low of $37.03 and a 12-month high of $47.63. The stock has a 50-day moving average price of $41.40 and a 200 day moving average price of $41.34.
Heineken Company Profile
Heineken N.V. is a Netherlands-based brewing company that produces, markets and distributes beer and other beverages worldwide. Its portfolio includes the flagship Heineken brand, along with Amstel, Birra Moretti, Desperados, Sol, Tiger and other regional and specialty brands. The company also offers cider and alcohol-free and low-alcohol beverage options in selected markets.
Founded in Amsterdam in 1864 by Gerard Adriaan Heineken, the company has grown from a Dutch brewery into an international beverage group.
Recommended Stories
- Five stocks we like better than Heineken
- Comfort Systems Earnings: AI Slowdown or More Growth Ahead?
- Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock
- 5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps
- Anthropic’s IPO Filing Reveals a Massive Opportunity for AI Infrastructure Giants
Receive News & Ratings for Heineken Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heineken and related companies with MarketBeat.com's FREE daily email newsletter.
